Home / Tobramycin / Australia
AU ATC J01GB01 · updated 3 Nov 2026
Tobramycin shortage in Australia
Is there a Tobramycin shortage in Australia?
Yes. As of 3 Nov 2026, 1 Tobramycin product is reported short in Australia. The company estimate for the return is 2 Apr 2027. Main reason: not stated.
Also short in United States, Canada, Germany, Italy, Sweden. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | Pfizer (Australia) TOBRAMYCIN (as sulfate) PF 80 mg/2 mL injection ampoule anticipated | 7 Jan 2027 | 2 Apr 2027 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.